BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26341700)

  • 1. Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection.
    Saitta C; Lanza M; Bertuccio A; Lazzara S; Navarra G; Raimondo G; Pollicino T
    Cancer Genet; 2015 Oct; 208(10):513-6. PubMed ID: 26341700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.
    Vivekanandan P; Torbenson M; Ramakrishna B
    J Gastrointest Cancer; 2011 Mar; 42(1):20-5. PubMed ID: 20963515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
    Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
    Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
    Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
    Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
    Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
    Chen L; Zhao H; Yang X; Gao JY; Cheng J
    Discov Med; 2014 Oct; 18(99):189-93. PubMed ID: 25336032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
    Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
    Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
    Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
    Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
    Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
    Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.
    Pollicino T; Squadrito G; Cerenzia G; Cacciola I; Raffa G; Craxi A; Farinati F; Missale G; Smedile A; Tiribelli C; Villa E; Raimondo G
    Gastroenterology; 2004 Jan; 126(1):102-10. PubMed ID: 14699492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult hepatitis B virus and hepatocellular carcinoma.
    Pollicino T; Saitta C
    World J Gastroenterol; 2014 May; 20(20):5951-61. PubMed ID: 24876718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
    Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
    J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
    Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF
    Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.